메뉴 건너뛰기




Volumn 111, Issue 5, 2014, Pages 894-902

Withacnistin inhibits recruitment of STAT3 and STAT5 to growth factor and cytokine receptors and induces regression of breast tumours

Author keywords

breast cancer; EGFR; gp130; STAT3; STAT5; Withacnistin

Indexed keywords

BETA INTERFERON; CYTOKINE RECEPTOR; GLYCOPROTEIN GP 130; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; GROWTH FACTOR RECEPTOR; INTERLEUKIN 6; NATURAL PRODUCT; PLATELET DERIVED GROWTH FACTOR; PLATELET DERIVED GROWTH FACTOR BB; PROTEIN BCL XL; PROTEIN MCL 1; STAT3 PROTEIN; STAT5 PROTEIN; UNCLASSIFIED DRUG; WITHACNISTIN;

EID: 84906936086     PISSN: 00070920     EISSN: 15321827     Source Type: Journal    
DOI: 10.1038/bjc.2014.349     Document Type: Article
Times cited : (27)

References (41)
  • 1
    • 47949089905 scopus 로고    scopus 로고
    • Persistent transactivation of EGFR and ErbB2/HER2 by protease-activated receptor-1 promotes breast carcinoma cell invasion
    • Arora P, Cuevas BD, Russo A, Johnson GL, Trejo J (2008) Persistent transactivation of EGFR and ErbB2/HER2 by protease-activated receptor-1 promotes breast carcinoma cell invasion. Oncogene 27(32): 4434-4445.
    • (2008) Oncogene , vol.27 , Issue.32 , pp. 4434-4445
    • Arora, P.1    Cuevas, B.D.2    Russo, A.3    Johnson, G.L.4    Trejo, J.5
  • 2
    • 79955504184 scopus 로고    scopus 로고
    • Combination of farnesyltransferase and Akt inhibitors is synergistic in breast cancer cells and causes significant breast tumor regression in ErbB2 transgenic mice
    • Balasis ME, Forinash KD, Chen YA, Fulp WJ, Coppola D, Hamilton AD, Cheng JQ, Sebti SM (2011) Combination of farnesyltransferase and Akt inhibitors is synergistic in breast cancer cells and causes significant breast tumor regression in ErbB2 transgenic mice. Clin Cancer Res 17(9): 2852-2862.
    • (2011) Clin Cancer Res , vol.17 , Issue.9 , pp. 2852-2862
    • Balasis, M.E.1    Forinash, K.D.2    Chen, Y.A.3    Fulp, W.J.4    Coppola, D.5    Hamilton, A.D.6    Cheng, J.Q.7    Sebti, S.M.8
  • 3
    • 84862000598 scopus 로고    scopus 로고
    • Dual inhibition of Jak2 and STAT5 enhances killing of myeloproliferative neoplasia cells
    • Bar-Natan M, Nelson EA, Walker SR, Kuang Y, Distel RJ, Frank DA (2012) Dual inhibition of Jak2 and STAT5 enhances killing of myeloproliferative neoplasia cells. Leukemia 26(6): 1407-1410.
    • (2012) Leukemia , vol.26 , Issue.6 , pp. 1407-1410
    • Bar-Natan, M.1    Nelson, E.A.2    Walker, S.R.3    Kuang, Y.4    Distel, R.J.5    Frank, D.A.6
  • 4
    • 34250349898 scopus 로고    scopus 로고
    • Design and synthesis of a new, conformationally constrained, macrocyclic small-molecule inhibitor of STAT3 via 'click chemistry'
    • Chen J, Nikolovska-Coleska Z, Yang CY, Gomez C, Gao W, Krajewski K, Jiang S, Roller P, Wang S (2007) Design and synthesis of a new, conformationally constrained, macrocyclic small-molecule inhibitor of STAT3 via 'click chemistry'. BioorgMed Chem Lett 17(14): 3939-3942.
    • (2007) BioorgMed Chem Lett , vol.17 , Issue.14 , pp. 3939-3942
    • Chen, J.1    Nikolovska-Coleska, Z.2    Yang, C.Y.3    Gomez, C.4    Gao, W.5    Krajewski, K.6    Jiang, S.7    Roller, P.8    Wang, S.9
  • 8
    • 0030840464 scopus 로고    scopus 로고
    • STATs and gene regulation
    • Darnell Jr JE (1997) STATs and gene regulation. Science 277(5332): 1630-1635.
    • (1997) Science , vol.277 , Issue.5332 , pp. 1630-1635
    • Darnell Jr., J.E.1
  • 9
    • 0036782706 scopus 로고    scopus 로고
    • Transcription factors as targets for cancer therapy
    • Darnell Jr JE (2002) Transcription factors as targets for cancer therapy. Nat Rev Cancer 2(10): 740-749.
    • (2002) Nat Rev Cancer , vol.2 , Issue.10 , pp. 740-749
    • Darnell Jr., J.E.1
  • 10
    • 84864917825 scopus 로고    scopus 로고
    • Small molecule inhibitors of signal transducer and activator of transcription 3 (Stat3) protein
    • Debnath B, Xu S, Neamati N (2012) Small molecule inhibitors of signal transducer and activator of transcription 3 (Stat3) protein. J Med Chem 55(15): 6645-6668.
    • (2012) J Med Chem , vol.55 , Issue.15 , pp. 6645-6668
    • Debnath, B.1    Xu, S.2    Neamati, N.3
  • 11
    • 84906939170 scopus 로고    scopus 로고
    • Development and validation of high performance liquid chromatography method for simultaneous estimation of flavonoid glycosides in Withania somnifera aerial parts
    • doi:10.1155/2014/351547
    • Deepak Mundkinajeddu, L.P. Sawant, Rojison Koshy, Praneetha Akunuri, Vineet Kumar Singh, Anand Mayachari, M.HM Sharaf, Murali Balasubramanian, Amit Agarwal. (2014) Development and validation of high performance liquid chromatography method for simultaneous estimation of flavonoid glycosides in Withania somnifera aerial parts. ISRN Anal Chem; doi:10.1155/2014/351547.
    • (2014) ISRN Anal Chem
    • Mundkinajeddu, D.1    Sawant, L.P.2    Koshy, R.3    Akunuri, P.4    Kumar Singh, V.5    Mayachari, A.6    Sharaf, M.H.M.7    Balasubramanian, M.8    Agarwal, A.9
  • 13
    • 0037818425 scopus 로고    scopus 로고
    • Granulocyte-macrophage colony-stimulating factor (GM-CSF) induces antiapoptotic and proapoptotic signals in acute myeloid leukemia
    • Faderl S, Harris D, Van Q, Kantarjian HM, Talpaz M, Estrov Z (2003) Granulocyte-macrophage colony-stimulating factor (GM-CSF) induces antiapoptotic and proapoptotic signals in acute myeloid leukemia. Blood 102(2): 630-637.
    • (2003) Blood , vol.102 , Issue.2 , pp. 630-637
    • Faderl, S.1    Harris, D.2    Van, Q.3    Kantarjian, H.M.4    Talpaz, M.5    Estrov, Z.6
  • 14
    • 78650528780 scopus 로고    scopus 로고
    • The role of Stat5 transcription factors as tumor suppressors or oncogenes
    • Ferbeyre G, Moriggl R (2011) The role of Stat5 transcription factors as tumor suppressors or oncogenes. Biochim Biophys Acta 1815(1): 104-114.
    • (2011) Biochim Biophys Acta , vol.1815 , Issue.1 , pp. 104-114
    • Ferbeyre, G.1    Moriggl, R.2
  • 16
    • 84859721377 scopus 로고    scopus 로고
    • JAK2 inhibition for the treatment of hematologic and solid malignancies
    • Harry BL, Eckhardt SG, Jimeno A (2012) JAK2 inhibition for the treatment of hematologic and solid malignancies. Expert Opin Investig Drugs 21(5): 637-655.
    • (2012) Expert Opin Investig Drugs , vol.21 , Issue.5 , pp. 637-655
    • Harry, B.L.1    Eckhardt, S.G.2    Jimeno, A.3
  • 18
    • 65549114590 scopus 로고    scopus 로고
    • ErbB2-mediated Src and signal transducer and activator of transcription 3 activation leads to transcriptional up-regulation of p21Cip1 and chemoresistance in breast cancer cells
    • Hawthorne VS, Huang WC, Neal CL, Tseng LM, Hung MC, Yu D (2009) ErbB2-mediated Src and signal transducer and activator of transcription 3 activation leads to transcriptional up-regulation of p21Cip1 and chemoresistance in breast cancer cells. Mol Cancer Res 7(4): 592-600.
    • (2009) Mol Cancer Res , vol.7 , Issue.4 , pp. 592-600
    • Hawthorne, V.S.1    Huang, W.C.2    Neal, C.L.3    Tseng, L.M.4    Hung, M.C.5    Yu, D.6
  • 19
    • 18344390418 scopus 로고    scopus 로고
    • ERBB receptors and cancer: The complexity of targeted inhibitors
    • Hynes NE, Lane HA (2005) ERBB receptors and cancer: the complexity of targeted inhibitors. Nat Rev Cancer 5(5): 341-354.
    • (2005) Nat Rev Cancer , vol.5 , Issue.5 , pp. 341-354
    • Hynes, N.E.1    Lane, H.A.2
  • 20
    • 0014628894 scopus 로고
    • Tumor inhibitors XXXIX. Active principles of Acnistus arborescens. Isolation and structural and spectral studies of withaferin A and withacnistin
    • Kupchan SM AW, Bollinger P, Doskotch RW, Smith RM, Renauld JA, Schnoes HK, Burlingame AL, Smith DH (1969) Tumor inhibitors. XXXIX. Active principles of Acnistus arborescens. Isolation and structural and spectral studies of withaferin A and withacnistin. J Org Chem 34(12): 3858-3866.
    • (1969) J Org Chem , vol.34 , Issue.12 , pp. 3858-3866
    • Kupchan, S.M.A.W.1    Bollinger, P.2    Doskotch, R.W.3    Smith, R.M.4    Renauld, J.A.5    Schnoes, H.K.6    Burlingame, A.L.7    Smith, D.H.8
  • 25
    • 78650499336 scopus 로고    scopus 로고
    • Signal transducer and activator of transcription 3 inhibitors: A patent review
    • Page BD, Ball DP, Gunning PT (2011) Signal transducer and activator of transcription 3 inhibitors: a patent review. Expert Opin Ther Pat 21(1): 65-83.
    • (2011) Expert Opin Ther Pat , vol.21 , Issue.1 , pp. 65-83
    • Page, B.D.1    Ball, D.P.2    Gunning, P.T.3
  • 27
    • 2942579547 scopus 로고    scopus 로고
    • A high-throughput fluorescence polarization assay for signal transducer and activator of transcription 3
    • Schust J, Berg T (2004) A high-throughput fluorescence polarization assay for signal transducer and activator of transcription 3. Anal Biochem 330(1): 114-118.
    • (2004) Anal Biochem , vol.330 , Issue.1 , pp. 114-118
    • Schust, J.1    Berg, T.2
  • 28
    • 33750982120 scopus 로고    scopus 로고
    • Stattic: A small-molecule inhibitor of STAT3 activation and dimerization
    • Schust J, Sperl B, Hollis A, Mayer TU, Berg T (2006) Stattic: a small-molecule inhibitor of STAT3 activation and dimerization. Chem Biol 13(11): 1235-1242.
    • (2006) Chem Biol , vol.13 , Issue.11 , pp. 1235-1242
    • Schust, J.1    Sperl, B.2    Hollis, A.3    Mayer, T.U.4    Berg, T.5
  • 29
    • 0043175471 scopus 로고    scopus 로고
    • Identification and characterization of signal transducer and activator of transcription 3 recruitment sites within the epidermal growth factor receptor
    • Shao H, Cheng HY, Cook RG, Tweardy DJ (2003) Identification and characterization of signal transducer and activator of transcription 3 recruitment sites within the epidermal growth factor receptor. Cancer Res 63(14): 3923-3930.
    • (2003) Cancer Res , vol.63 , Issue.14 , pp. 3923-3930
    • Shao, H.1    Cheng, H.Y.2    Cook, R.G.3    Tweardy, D.J.4
  • 30
    • 33847323129 scopus 로고    scopus 로고
    • Epidermal growth factor receptor mutations in lung cancer
    • Sharma SV, Bell DW, Settleman J, Haber DA (2007) Epidermal growth factor receptor mutations in lung cancer. Nat Rev Cancer 7(3): 169-181.
    • (2007) Nat Rev Cancer , vol.7 , Issue.3 , pp. 169-181
    • Sharma, S.V.1    Bell, D.W.2    Settleman, J.3    Haber, D.A.4
  • 31
    • 0034676267 scopus 로고    scopus 로고
    • Induction of p21WAF1/CIP1 and cyclin D1 expression by the Src oncoprotein in mouse fibroblasts: Role of activated STAT3 signaling
    • Sinibaldi D, Wharton W, Turkson J, Bowman T, Pledger WJ, Jove R (2000) Induction of p21WAF1/CIP1 and cyclin D1 expression by the Src oncoprotein in mouse fibroblasts: role of activated STAT3 signaling. Oncogene 19(48): 5419-5427.
    • (2000) Oncogene , vol.19 , Issue.48 , pp. 5419-5427
    • Sinibaldi, D.1    Wharton, W.2    Turkson, J.3    Bowman, T.4    Pledger, W.J.5    Jove, R.6
  • 32
    • 18844370367 scopus 로고    scopus 로고
    • Cucurbitacin Q: A selective STAT3 activation inhibitor with potent antitumor activity
    • Sun J, Blaskovich MA, Jove R, Livingston SK, Coppola D, Sebti SM (2005) Cucurbitacin Q: a selective STAT3 activation inhibitor with potent antitumor activity. Oncogene 24(20): 3236-3245.
    • (2005) Oncogene , vol.24 , Issue.20 , pp. 3236-3245
    • Sun, J.1    Blaskovich, M.A.2    Jove, R.3    Livingston, S.K.4    Coppola, D.5    Sebti, S.M.6
  • 33
    • 39749112548 scopus 로고    scopus 로고
    • Cucurbitacin Q: A selective STAT3 activation inhibitor with potent antitumor activity
    • Sun J, Blaskovich MA, Jove R, Livingston SK, Coppola D, Sebti SM (2008) Cucurbitacin Q: a selective STAT3 activation inhibitor with potent antitumor activity. Oncogene 27: 1344.
    • (2008) Oncogene , vol.27 , pp. 1344
    • Sun, J.1    Blaskovich, M.A.2    Jove, R.3    Livingston, S.K.4    Coppola, D.5    Sebti, S.M.6
  • 36
    • 84877614822 scopus 로고    scopus 로고
    • Truncated p110 ERBB2 induces mammary epithelial cell migration, invasion and orthotopic xenograft formation, and is associated with loss of phosphorylated STAT5
    • Ward TM, Iorns E, Liu X, Hoe N, Kim P, Singh S, Dean S, Jegg AM, Gallas M, Rodriguez C, Lippman M, Landgraf R, Pegram MD (2013) Truncated p110 ERBB2 induces mammary epithelial cell migration, invasion and orthotopic xenograft formation, and is associated with loss of phosphorylated STAT5. Oncogene 32(19): 2463-2474.
    • (2013) Oncogene , vol.32 , Issue.19 , pp. 2463-2474
    • Ward, T.M.1    Iorns, E.2    Liu, X.3    Hoe, N.4    Kim, P.5    Singh, S.6    Dean, S.7    Jegg, A.M.8    Gallas, M.9    Rodriguez, C.10    Lippman, M.11    Landgraf, R.12    Pegram, M.D.13
  • 37
    • 1042302005 scopus 로고    scopus 로고
    • The STATs of cancer - New molecular targets come of age
    • Yu H, Jove R (2004) The STATs of cancer - new molecular targets come of age. Nat Rev Cancer 4(2): 97-105.
    • (2004) Nat Rev Cancer , vol.4 , Issue.2 , pp. 97-105
    • Yu, H.1    Jove, R.2
  • 38
    • 70350500225 scopus 로고    scopus 로고
    • STATs in cancer inflammation and immunity: A leading role for STAT3
    • Yu H, Pardoll D, Jove R (2009) STATs in cancer inflammation and immunity: a leading role for STAT3. Nat Rev Cancer 9(11): 798-809.
    • (2009) Nat Rev Cancer , vol.9 , Issue.11 , pp. 798-809
    • Yu, H.1    Pardoll, D.2    Jove, R.3
  • 40
    • 77649178678 scopus 로고    scopus 로고
    • A novel small-molecule disrupts Stat3 SH2 domain-phosphotyrosine interactions and Stat3-dependent tumor processes
    • Zhang X, Yue P, Fletcher S, Zhao W, Gunning PT, Turkson J (2010) A novel small-molecule disrupts Stat3 SH2 domain-phosphotyrosine interactions and Stat3-dependent tumor processes. Biochem Pharmacol 79(10): 1398-1409.
    • (2010) Biochem Pharmacol , vol.79 , Issue.10 , pp. 1398-1409
    • Zhang, X.1    Yue, P.2    Fletcher, S.3    Zhao, W.4    Gunning, P.T.5    Turkson, J.6


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.